Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms.
Traina F, Visconte V, Elson P, Tabarroki A, Jankowska AM, Hasrouni E, Sugimoto Y, Szpurka H, Makishima H, O'Keefe CL, Sekeres MA, Advani AS, Kalaycio M, Copelan EA, Saunthararajah Y, Olalla Saad ST, Maciejewski JP, Tiu RV.
Traina F, et al. Among authors: o keefe cl.
Leukemia. 2014 Jan;28(1):78-87. doi: 10.1038/leu.2013.269. Epub 2013 Sep 18.
Leukemia. 2014.
PMID: 24045501